Biodexa Pharmaceuticals (BDRX) Enterprise Value Growth (3y) (2016 - 2025)
Biodexa Pharmaceuticals (BDRX) Enterprise Value Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Biodexa Pharmaceuticals | 18.43 Bn | 18.43 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -50.55% |
| Jun 30, 2025 | 12.69% |
| Dec 31, 2024 | 45.94% |
| Jun 30, 2024 | -2.78% |
| Dec 31, 2023 | 9.40% |
| Jun 30, 2023 | -6.77% |
| Dec 31, 2022 | 38.14% |
| Jun 30, 2022 | 11.19% |
| Dec 31, 2021 | -65.06% |
| Jun 30, 2021 | -1.56% |
| Dec 31, 2020 | 17.16% |
| Jun 30, 2020 | 12.06% |
| Dec 31, 2019 | 13.74% |
| Jun 30, 2019 | -3.62% |
| Dec 31, 2018 | 50.29% |
| Dec 31, 2017 | 28.54% |
| Dec 31, 2016 | -78.26% |